CNS Pharmaceuticals
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has CNS Pharmaceuticals's balance sheet done over the years? Its assets were worth $1,700,853 last year, which is less than in the previous period. 361% of CNS Pharmaceuticalsโ€™s total assets is currently financed by debt. Its liabilities reached the amount of $6,132,968, which means an increase by 25% compared compared to last year.

Debt to Assets

CNS Pharmaceuticals, Inc. (NASDAQ:CNSP): Debt to assets
2017 162194 220.72K 136.09%
2018 683333 1.23M 180.39%
2019 7912075 310.99K 3.93%
2020 15853412 1.90M 12.02%
2021 8757385 2.13M 24.39%
2022 13053115 4.92M 37.69%
2023 1700853 6.13M 360.58%

CNSP Balance Sheet (2017 โ€“ 2023)

2023 2022 2021 2020 2019 2018 2017
Assets
Current assets:
Cash and cash equivalents
548.72K10.05M5.00M14.03M7.24M282.73K110.54K
Short term investments
0000000
Net receivables
0000000
Inventory
0000000
Other current assets
1.04M2.50M2.47M1.45M652.62K33K51.65K
Total current assets
1.59M12.56M7.47M15.49M7.89M588.13K162.19K
Non-current assets:
Property, Plant and Equipment
4.93K5.66K16.10K23.43K18.16K00
Goodwill
0000000
Intangible assets
0000000
Long term investments
0000000
Other non-current assets
104.75K482.80K1.26M334.13K-395.2K0
Total non-current assets
109.68K488.47K1.27M357.56K18.16K95.2K0
Total assets
1.70M13.05M8.75M15.85M7.91M683.33K162.19K
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
0000023.59K0
Short term debt
300.80K409.96K387.79K439.29K0316.91K121.82K
Total current liabilities
6.13M4.92M2.13M1.90M310.99K1.23M220.72K
Non-current liabilities:
Long term debt
0000000
Deferred tax
0000000
Other non-current liabilities
04.09M00000
Total non-current liabilities
04.09M000445.78K179.32K
Total liabilities
6.13M4.92M2.13M1.90M310.99K1.23M220.72K
Data sourceData sourceData sourceData sourceData source